3 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-22-019305
Form type: Form 3
Filer: Quince Therapeutics, Inc.
CIK: CIK 1662774
Filed: Mar 16, 2022
Reporting period: Mar 14, 2022
Description: Initial ownership

Documents

0001209191-22-019305-index.htm

Complete submission

0001209191-22-019305.txt

directory listing

Filed by

Quince Therapeutics, Inc.